Meet the Doctors

Dr. David Steiger, MD - Chief of Division

Dr. David Steiger Dr. David Steiger
Chief of Division

Dr. David Steiger, Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Beth Israel, Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai.

Dr. David Steiger MD became Chief of the Pulmonary, Critical Care and Sleep Medicine in May 2015.

Following medical residency training and Chief Residency at St Lukes Roosevelt Hospital , New York City, he completed his fellowship training in Pulmonary and Critical Care Medicine at University of California, San Francisco. He worked as Director of the I.C.U at the Hospital for Joint Diseases, NYU Medical Center, before assuming his new position at Mount Sinai Beth Israel.

I have been involved in clinical and basic science research throughout my academic career, and have been the recipient of a number of grants that have supported basic science, and clinical research. I am the author or co-author of 25 papers, and 45 abstracts. Initially I pursued basic science research focused on understanding the mechanisms responsible for mucus hypersecretion in the airways – secondary to airway inflammation from infection, and noxious non-infectious irritants. My subsequent research has been clinically based. I have published papers and abstracts on multiple facets of thromboembolic disease – including outcomes based research, the utility of non-invasive methods of diagnosis of pulmonary embolism (P.E.), the prevalence of thrombophilic states in patients with P.E., the role of retrievable inferior vena cava filters in the perioperative period, including the use of the inferior vena cava filter for primary prophylaxis. With respect to the field of perioperative management. I have been the senior author of a study describing the role of non-autologous blood transfusion on the increased risk of wound infections, and have written on the management of the perioperative patient with sleep apnea.

I have developed a busy faculty clinical practice since Fellowship. I am particularly interested in following patients with thromboembolic disease, C.O.P.D., and interstitial lung disease.

With my recent arrival at MSBI, we are embarking on many new clinical research projects relating to thromboembolic disease. We are investigating the utility of the age adjusted D dimer, the presentation of pulmonary emboli in the elderly, and the prevalence of “clot-in-transit” in patients with pulmonary embolism. In addition, we are evaluating the efficacy and safety of early discharge from hospital after a P.E. using a validated management algorithm. We will be studying the role of the new oral anticoagulants in the safety and efficacy of treating patients discharged from hospital within 24 hours of being diagnosed with a P.E.

We are developing a comprehensive, multidisciplinary lung cancer screening program, where we will collaborate with thoracic surgery, radiology, and oncology at MSBI.

Peer Reviewed Original Publications

  1. Poewe W, Lees AJ, Steiger DJ, Stern GM. “Foot Dystonia in Parkinsons Disease: Clinical Phenomenology and Neuropharmacology. “ Advances in Neurology. 1986. 45: 357-360
  2. Schnapp L, Geigen S, Campagna A, Fahy J, Steiger D, Eng N, Hadley W, Hopewell P, Stansell J “Toxoplasma Gondii Pneumonia in Patients Infected with the Human Immunodeficiency Virus. “Archives of Internal Medicine 1992; 152:1073-1077.
  3. Fahy JV, Chin DP, Schnapp LM, Steiger DJ, Schaumberg T, Geigen SM, Klein J, Hopewell P. “The influence of prophylactic aerosolized pentamidine on the presentation, diagnosis and radiographic appearance of Pneumocystis Carinii Pneumonia.” Am Rev Resp Dis 1992;146: 844-848.
  4. Pennington DW, Gold WM, Gordon RL, Steiger DJ, Ring EJ, Golden JA. “Treatment of PulmonaryArteriovenous Malformations by Therapeutic Embolization. “ Am Rev Resp Dis 1992: 145, 5; 1047-1052
  5. Cozens AL, Yezzi MJ, Yamaya M, Steiger DJ Wagner JA, Gruenert DC, et al. “A transformed humanepithelial cell line that retains tight junctions post crisis. “ In Vitro Cell. Dev. Biol. 1992: 28A, 735-744.
  6. Yung R., Weinacker A., Steiger DJ, Miller T., Salmon C., Chernoff D., Kuntz S., Golden JA. “Utility of unilateral bilobar (upper and middle lobe) bronchoalveolar lavage as the sole method of diagnosing pneumocystis carinii pneumonia in patients on prophylactic aerosolized pentamidine. “ Am Rev Resp Dis 1993, 148: 1563-1566.
  7. Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. “Markers of mucus secretion andDNA levels in induced sputum from asthmatic and healthy subjects. “ Am Rev Resp Dis 1993, 147:1132-1137.
  8. Steiger DJ, Fahy JV, Boushey HA, Finkbeiner WE, and Basbaum CB. “Use of mucin antibodies andcDNA probes to quantify hypersecretion in vivo in human airways.” Am J Respir Cell Mol Biol 1994, 10:538-545.
  9. Steiger DJ, Hotchkiss JA, Bajaj L., Harkema JR,, Basbaum CB. “Concurrent increases in the storage and release of mucin-like molecules by rat airway epithelial cells in response to bacterial endotoxin. “ Am. J. Respir.. Cell Mol. Biol. 1995,12:307-314.
  10. Della Valle CJ, Steiger DJ, DiCesare PE. “Thromboembolism Following Hip and Knee Arthroplasty. “J.Am. Acad. Ortho. Surg 1998;6:327-336.
  11. Della Valle CJ, Jazrawi LM, DiCesare PE, Steiger DJ. “Paradoxical Embolism Following Major Orthopedic Surgery in Patients with Pulmonary Embolism: A Report of Two Cases.” J. Bone and Joint Surg 1999, 81A 108-110.
  12. Della Valle CJ, Jazrawi LM, Steiger DJ, DiCesare PE. “Anticoagulant Treatment of Thromboembolismwith Intravenous Heparin in the Early Postoperative Period Following Total Joint ArthroplastyJ. “Bone and Joint Surg 2000 Feb;82 (2):207-212.
  13. Della Valle CJ, Issack PS, Steiger DJ, DiCesare PE. “Potential Genetic Markers Predictive of Postoperative Thromboembolism Complicating Total Hip and Total Knee Arthroplasty. “ The University of Pennsylvania Orthopedic Journal 13: 78-82, 2000.
  14. Della Valle CJ, Issack PS, Steiger DJ, Fang C, DiCesare PE. “The Relationship of the Factor V Leiden Mutation and the Deletion-Deletion Polymorphism of the Angiotensin Converting Enzyme to Postoperative Thromboembolic Events Following Total Joint Arthroplasty..” BMC Musculoskeletal Disorders 2:1, 2001.
  15. Parikh SN, Stuchin SA, Maca C, Fallar E, Steiger DJ. “Sleep Apnea Syndrome in Patients Undergoing Total Joint Arthroplasty.” The Journal of Arthroplasty 2002,17,5:635-642.
  16. Alfonso DT, Toussaint J, Alfonso BD, Strauss EJ, Steiger DJ, DiCesare PE. “Non-surgical Complications After Total Hip Replacement. “ Am. J Orthop. 2006; 35 (11) 503-510.
  17. Strauss EJ, Egol K, Alaia M, Hansen D, Bashar M, Steiger DJ. “The Use of retrievable Inferior Vena Cava Filters in Orthopedic Surgery Patients.” Journal of Bone and Joint Diseases 2008; 90(5) 662-667.
  18. Charles HW, Black M, Kovacs S, Gohari A, Arampulikan J, McCann JW, Clark TW, Bashar M, Steiger D. “Inferior Vena Cava Filter: Retrievability and Safety. “ J Vasc Interv Radiol. June 26 2009
  19. Schwarzkopf R, Chung C, Park J, Walsh M, Spivak J, Steiger D. “The Effect of Perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. “ Spine 2010; 35 (3) 340-346.
  20. Oberweis BS, Cuff G, Rosenberg A, Pardo, Nardi MA, Guo Y, Dweck E, Marshall M, Steiger D Stuchin S, Berger JS. “Platelet Aggregation and Coagulation Factors in Orthopedic Surgery. Journal of Thrombosis and Thrombolysis. “ 2014 May 30;164-169
  21. Vira S, MD; Alaia M, MD; Rybak L, MD; Steiger D, Jaffe F, MD. “Utility of duplex ultrasonography inpostoperative DVT detection of patients undergoing primary total knee and hip replacement.” (submitted)
  22. Ramme A, Cohen A, Iturrate E, Steiger D, Dweck E, Hutzler D, Bosco J. "End Tidal Carbon Dioxide (ETCO2) Excludes Pulmonary Embolism in Post-Operative Orthopaedic Patients" Journal of Bone and Joint Surgery (submitted)

Other Peer Reviewed Publications

  1. Adamson R, Rapkiewicz A, Yazici Y, Steiger D. “Fatal Acute Necrotising Eosinophilic Myocarditis due to Adalimumab in a Patient with Relapsing Polychondritis. “ Journal of Clinical Rheumatology 2013 Oct;19(7):386-9.
  2. Danckers M, Fang Z, Nimeh D, Belmont HM, Steiger D “ Pulmonary Metastases in a Patient with Simultaneous Bladder and Relapsing Granulomatosis with Polyangiitis.” American Journal of Case Reports 2015, May 14;16:287-91

Reviews, Books, and Book Chapters

  1. Steiger DJ. “Thromboembolic disease in the Orthopedic Patient. “ Orthopedics. A Comprehensive Study Guide. 1999 Ed. Zuckerman J.D. Pub. McGraw Hill
  2. Steiger DJ. “Medical Complications in the Orthopedic patient.” Orthopedics. A Comprehensive StudyGuide. 1999 Ed. Zuckerman J.D. Pub. McGraw Hill
  3. Steiger DJ. “Alpha 1 Antitrypsin Deficiency: Advances in Management, in Ninth Annual "Recent Advances in Pulmonary and Critical Care Medicine" 1990 - Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco School of Medicine.

ABSTRACTS

  1. 1991 Steiger DJ, Golden JA. Effect of Prophylactic Aerosolized Pentamidine Therapy on Diagnostic Utility of Bronchoalveolar Lavage. Annual Meeting of American College of Chest Physicians
  2. 1991 Steiger DJ, Gallup M, Fahy JV, Boushey HA, Basbaum CB. Co-amplification of Mucin and Keratin cDNAs in Human Tissue Samples. Annual Meeting American Thoracic Society
  3. 1992 Steiger DJ, Gallup M, Fahy JV, Finkbeiner WE, Boushey HA, Basbaum CB. Elisa and Polymerase Chain Reaction based methods for semi-quantitative detection of mucin and mucin mRNA in-vivo in human airways. Annual Meeting American Thoracic Society
  4. 1993 Fahy JV, Steiger DJ, Liu J, Finkbeiner WE, Basbaum CB, Boushey HA. Markers of inflammation and mucus secretion in induced sputum from asthmatic and healthy subjects. J All Clin Imm 1993,91: A154.
  5. 1993 Omori H, Dohrman AF, Gallup M, Steiger DJ, Tsuda T, Kai H, Gum JR Jr., Kim YS, Basbaum CB. Molecular Cloning of the 5' end non-tandem repeat region of a rat MUC 2 mucin gene homologue: Evidence for expression in both intestine and airway. Am Soc Cell Biol. 1993
  6. 1993 Steiger DJ, Bajaj L., Omori H., Harkema JR, Hotchkiss JA, Basbaum CB. Endotoxin induces mucingene activation in rat airways. Annual Meeting American Thoracic Society
  7. 1996 Burschtin O, Rom WN, Steiger DJ. Diagnosis and clinical characteristics of thrombo-embolic disease in an orthopedic hospital. Annual Meeting American Thoracic Society
  8. 1997 Burschtin O, Rom WN, Rosenberg AD, Steiger DJ. Post Obstructive Pulmonary Edema Following Laryngospasm. Annual Meeting American Thoracic Society
  9. 1998 Sauthoff H, Rom WN, Steiger DJ. The Role of Pulmonary Arterial Catheterisation in the Peri-operative Period in High Risk Patients. Annual Meeting of American College of Chest Physicians
  10. 1999 Sauthoff H, Della Valle c, Sclossberg P, Rosen R, Steiger DJ. Efficacy and Complications of Inferior Vena Cava Filter Placement in Orthopedic Patients with Pulmonary Embolism or Deep Venous Thrombosis. Annual Meeting American Thoracic Society
  11. 2000 Goldenberg R, Fallar E, Maca C, Rom WN, Steiger DJ. The Utility of a Clinical Model and Chest C.T. Angiogram in Patients With Suspected Pulmonary Embolism. Annual Meeting American Thoracic Society
  12. 2001 Maca C, , Fallar E, Raja B, Costa ME, Rom WN, Steiger DJ. Comparison of CT Venography and Pulmonary Angiography with Lower Extremity Sonography in Patients with Suspected Thromboembolic Disease. Annual Meeting American Thoracic Society
  13. 2001 Goldenberg R, Della Valle CJ, Fang C, DiCesare PE, Rom WN, Steiger DJ. The Role of the Prothrombin Gene G20210A Mutation in Thromboembolic Complications following Total Hip and Knee Arthroplasty. Annual Meeting American Thoracic Society
  14. 2002 Maca C, Lombino M, Koval K. Rom WN, Steiger DJ. The Role of CT Venography and Pulmonary Angiography in Pelvic Trauma Patients on the Decision to insert Perioperative Inferior Vena Cava Filters. Annual Meeting American Thoracic SocietyAguila E, Steiger DJ, Rom WN, Addrizzo-Harris. Are Lower Extremity Doppler Ultrasounds Required Before the Placment of Sequential Compression Devices.

Annual Meeting American Thoracic Society

  1. 2003 Felner K, Bashar M, Rom WN, Steiger DJ. Utility of Cardiac Troponin 1Levels in Acute Pulmonary Embolism. Annual Meeting American Thoracic Society
  2. 2004 Puthawala K, Bashar M, Rom WN, Steiger DJ. Utility of C.T. Venography in Patients withPulmonary Embolism Diagnosed by C.T. Angiogram. Annual Meeting American Thoracic Society
  3. 2004 Kline MY, Steiger DJ. A Case of a 52 year female with Scleroderma, Pulmonary Fibrosis, andRecurrent Acute Respiratory Distress. Annual Meeting of American College of Chest Physicians
  4. 2005 Kline MY, Bashar M, Rom WM SteigerDJ. Retrievable Vena Cava Filters: Clinical Experience in 33 Patients. Annual Meeting American Thoracic Society
  5. 2006 Patrawalla A, Bashar M, Hansen D, Rom WM, Burschtin O, Steiger DJ. Utility of Non-invasive Ventilation in the Perioperative Management of patients With Suspected obstructive Sleep Apnea. Annual Meeting American Thoracic Society
  6. 2007 Dweck E, Bashar M, Hansen D, Clark T, Rom W, Steiger D Utility of Retrievable Inferior Vena Cava Filters for Primary Prophylaxis of Pulmonary Embolism in High-Risk Preoperative Orthopedic Patients. Annual Meeting of American College of Chest Physicians
  7. 2008 Kovacs S, Steiger D, Charles H, Clark T. Predictors of Tilting of the Bard G2 Filter. Society ofInterventional Radiology 33rd Annual Meeting
  8. 2008 Dweck E, Bonura E, ward J, Nomikos G, Bashar M, Hansen D, , Rom W, Steiger D. Right Ventricular Dysfunction due to Submassive Pulmonary Embolism in Orthopedic Surgery Patients Does Not Predict Adverse Outcome . Annual Meeting American Thoracic Society
  9. 2008 Bauer K, Steiger D Fatal Hypersensitivity Myocarditis in a patient with Relapsing Polychondritis. Annual Meeting of American College of Chest Physicians
  10. 2009 Uppal A, Steiger D, D.Abi-Fadel, Shreve M, Bashar M, Reid M, Rom WN, Dweck E. PulmonaryEmbolism Severity Index in Patients with Acute Pulmonary Embolism after Orthopedic Surgery.) Annual Meeting American Thoracic Society
  11. 2010 D.Abi-Fadel, Uppal A, Dweck E, Bashar M, Bonura E, reid M, Rom W, Steiger D. In-hospital Pulmonary Embolism Mortality in Orthopedic Surgical Patients. Annual Meeting American Thoracic Society
  12. 2010 Shariat C, Dweck E, Lee M, Basavaraj C, Law S, Bashar M, Schiesel E, Reid M, Rom WN, Steiger D.Safety and Efficacy of Retrievable Inferior Vena Cava Filters in a High Risk Orthopedic Population. Annual Meeting American Thoracic Society
  13. 2010 Basavaraj A, Steiger D, Lee M, Rom WN, Dweck D. Shock Index in Patients with Acute Pulmonary Embolism after Orthopedic Surgery. Annual Meeting American Thoracic Society
  14. 2010 Mulaikal E, Fridman D, Dweck E, Rom WN, Adamson R, Steiger D. Measles Pneumonia in an Immunocompetent, Unvaccinated Adult Host.
  15. 2010 Basavaraj A, Gomez-Marquez, Steiger D, Lee M, D Annual Meeting American Thoracic Society
  16. 2011 Dweck D. Streptococcus pneumoniae bacteremia following flexible bronchoscopy. Annual Meeting American Thoracic Society
  17. 2012 Danckers M, Steiger D Metastatic Bladder Cancer in a Patient with Relapsing Granulomatosis with Polyangiitis American College of Chest Physicians. Annual Meeting of American College of Chest Physicians
  18. 2012 Oberweis B, Cuff G, Rosenberg AD, Pardo L, Marshall M, Guo Y, Steiger D, Stuchin S, Berger J. Platelet activation Increases During the Perioperative Period of Orthopedic Surgery. ASA Annual Meeting October 2012; A 836.
  19. 2012 Oberweis B, Cuff G, Rosenberg AD, Pardo L, Marshall M, Guo Y, Steiger D, Stuchin S, Berger J.Platelet activation Increases During the Perioperative Period of Orthopedic Surgery. ASA Annual Meeting October 2012; A 836.
  20. 2013 E. Mulaikal, D. Steiger , V. Mukherjee, B. Steiger, N. Siegel, W.N. Rom, E. Dweck, The Clinical Significance Of Isolated Subsegmental Pulmonary Embolism Following Orthopedic Surgery. Am. J. Resp. and Crit. Care Med 2013 Proceedings of ATS 2013
  21. 2013 Mulaikal E, Steiger D , Mukherjee V, Steiger B, Siegel N, Rom WN, Steiger D, Dweck D, The Clinical Significance Of Isolated Subsegmental Pulmonary Embolism Following Orthopedic Surgery. Annual Meeting American Thoracic Society
  22. 2013 Oberweis B, Rosenberg A, Guo Y, Marshall M, Steiger D, Stuchin S, Berger J. Changes in Hemostasis During the Perioperative Period of Orthopedic Surgery. XXIV Congress of the Int. Soc. On Thrombosis. 2013
  23. 2013 Danckers M, Steiger D Metastatic Bladder Cancer in a Patient with Relapsing Granulomatosiswith Polyangiitis 12th Annual Department of Medicine Research Day. NYU School of Medicine
  24. 2013 Oberweis B, Rosenberg A, Guo Y, Marshall M, Steiger D, Stuchin S, Berger J. Changes in Hemostasis During the Perioperative Period of Orthopedic Surgery. NYU School of Medicine
  25. 2014 Edusei E, Vaze R, Karia R, Slover J, Steiger D. Evidence of baseline neurocognitive Impairment prior to Total Joint Replacement. Sir Robert Jones Symposium NYU Medical Center
  26. 2014 Slover J, Edusei E, Karia R, Band P, Steiger D. Postoperative Neurocognitive Dysfunction Following Hip or Knee Arthroplasty. Am. J. Resp. and Crit. Care Med. Proceedings of ATS 2015 (submitted).
  27. 2014 Zakhary,B, Dweck E, Segal L, Steiger D. Acute Pulmonary Emboli after Bleomycin Sclerotherapy for a Congenital Venous Malformation. Am. J. Resp. and Crit. Care Med. Proceedings of ATS 2015 (submitted).
  28. 2014 Cohen A, Ramme A, Iturrate E, Hutzler L, Dweck E, Steiger D, Bosco J. Prediction of Pulmonary Embolism in Postoperative Orthopedic Patients using End Tidal Carbon Dioxide Measurements. Society of Hospital Medicine
Back to top

Paru Patrawalla, MD, FCCP - Program Director

Dr. David Steiger Paru Patrawalla, MD, FCCP
Program Director

Program Director, Pulmonary and Critical Care Medicine Fellowship, Director of Simulation and Ultrasound, Department of Medicine, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai

Dr. Paru Patrawalla joined Mount Sinai Beth Israel as the Program Director for the Pulmonary and Critical Care Medicine Fellowship and Director of Simulation and Ultrasound in 2015. She is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Patrawalla received both her undergraduate and medical degrees from Brown University. She completed her residency training in Internal Medicine at Boston Medical Center, where she was also Chief Medical Resident. Dr. Patrawalla went on to complete her fellowship in Pulmonary and Critical Care Medicine at New York University, where she also served as Chief Fellow.

Dr. Patrawalla has been a leader in the training and assessment of critical care ultrasound locally, regionally and nationally. Since 2013, she has been the co-chair of several national courses on critical care ultrasonography given by the American College of Chest Physicians (ACCP) and reviewer for the only national assessment-based certificate for critical care ultrasound. Her academic interests include point-of-care ultrasound training and evaluation, bedside teaching and competency-based education. She has been awarded several research grants, including the NYU Program for Medical Education Innovations and Research grant in 2011 to support her study, Fellow Skill Assessment in Critical Care Ultrasound and the APCCMPD/ACCP/ATS Education Research Award in 2012 for her study, Impact of Faculty Development on Fellow Ultrasound Skill Evaluation.

Dr. Patrawalla has maintained a broad scope of clinical activity, focused primarily on inpatient pulmonary and critical care medicine. She has remained at the forefront of technological innovations by developing proficiency in the use of endobronchial ultrasound and point-of-care ultrasound.

Publications

Peer-Reviewed Publications

  1. SR Kumar, N Gopalan, P Patrawalla, P Menon, K Mayer and S Swaminathan, Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis, Int J STD AIDS June 2012 vol. 23 no. 6 419-423
  2. P Patrawalla, A. Kazeros, L. Rogers, Y. Shao, M. Liu, M.E. Fernandez-Beros, S. Shang, J. Reibman, Application of the asthma phenotype algorithm from the severe asthma research program to an urban population, 2012 ;7(9):e44540-e44540 e44540, PLoS ONE
  3. A Kazeros, M Maa, P Patrawalla, M Liu, Y Shao, M Qian, M Turetz, S Parsia, C Caplan-Shaw, K Berger, R Goldring, L Rogers, J Reibman. Elevated Peripheral Eosinophils Are Associated with New-Onset and Persistent Wheeze and Airflow Obstruction in World Trade Center-Exposed Individuals. Journal of Asthma 2013 50:1, 25-32
  4. P Patrawalla, “How Do We Learn? Achieving Mastery in Pleural Ultrasound.” Chest Physician. Dec 2013
  5. A Uppal; L Evans; N Chitkara; P Patrawalla; M Mooney; D Addrizzo-Harris; E Leibert; J Reibman; L Rogers; K Berger; J Tsay; W Rom. "In search of the silver lining". Annals of the American Thoracic Society. 2013 Apr;10(2):135-142
  6. M Danckers; V Mukherjee; P Patrawalla. “Duplicated Renal Collecting System” 2013 May; 433-441, American journal of the medical sciences — id: 1046792, year: 2013, vol: page: 433
  7. D Daglian; P Patrawalla. “Pregnant Patient with Progressive Hypoxemic Respiratory Failure.”Ultrasound Corner, CHEST Journal 147.6 (2015): e205-e207.
  8. P Patrawalla; L Eisen; A Shiloh; B. Shah; W. Wise; L. Evans; P. Mayo; D. Szyld. Development and Validation of an Assessment Tool for Competency in Critical Care Ultrasound, Journal of Graduate Medical Education, in press

Books and Book Chapters

  1. P Patrawalla, "Competence, Credentialing and Certification." Point of Care Ultrasound. Oxford: Saunders, 2014. 369-73. Print.

Abstracts

  1. Q Cheng, M Liu, L Rogers, M Fernandez-Beros, J Filner, J Hirschhorn, H Lyon, P Gregersen, M Seldin, P Patrawalla, J Reibman. Replication Study of Association of IL13 Pathway Polymorphisms and Asthma Using an Admixed Urban Population. Poster presentation, American Thoracic Society, International Conference, May 2009
  2. P Patrawalla, L Evans. Hemoptysis In A Young Chinese Man: A Case of Primary Lymphoepithelioma-like Carcinoma of the Lung. Case Presentation, Chest Conference, Nov 2009; 136: 48S.
  3. P Patrawalla, L Rogers, M Liu, Q Cheng, ME Fernandez-Beros, J Reibman. Environmentaltobacco smoke exposure and asthma control in an adult urban population. Poster presentation, American Thoracic Society, International Conference, May 17, 2010.
  4. Y Shao, M Liu, Q Cheng, A Kazeros, P Patrawalla, M Qian, L Rogers, M.E. Fernandez-Beros, J Reibman. Association Of SNPs In IL7R With Derived Asthma Phenotypes In An Urban Admixed Cohort. Poster presentation, American Thoracic Society, International Conference, May 2011.
  5. J Tsay, D Raptis, P Patrawalla, E Leibert. Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Compared With Wang Transbronchial Needle Aspiration, Poster presentation, American Thoracic Society, International Conference, May 2011, Am J Respir Crit Care Med 183;2011:A1570
  6. D Raptis, J Tsay, P Patrawalla, E Leibert. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Under General Anesthesia Versus Conscious Sedation. Poster presentation, American Thoracic Society, International Conference, May 2011, Am J Respir Crit Care Med 183; 2011:A1581
  7. Martin, Y; Callahan, C; Patrawalla, P; Evans, L. Relapsing Hodgkin Lymphoma Incidentally Found to Have Endobronchial Involvement: A Case Report, Case Presentation, Chest Conference, Oct 2011
  8. Lee Y, Garcia L, Smith R, Patrawalla P. Immune Reconstitution Inflammatory Syndrome Presenting As Pneumocystis Pneumonia After Filgrastrim-Induced Neutrophil Recovery. CHEST. 2012;142(4_MeetingAbstracts):168A-168A.
  9. Lee, Y I; Egan, J; Loganathan, R; Patrawalla, P. "Lymphoid interstitial pneumonia-like pulmonary infiltration in a patient with Castleman's disease and Sjogren's syndrome [Meeting Abstract]". Chest. 2013 October 2013;144(4):-
  10. Kim, H J; Seides, B; Mulaikal, E; Mukherjee, V; Eiss, B; Patrawalla, P. "Silicone embolism syndrome (SES): Still out there [Meeting Abstract]". Chest. 2013 October 2013;144(4):-
  11. Egan, J; Lee, Y I; Patrawalla, P; Loganathan, R. "Pulmonary histoplasmosis presenting in a man with AIDS [Meeting Abstract]". Chest. 2013 October 2013;144(4):-
  12. P Patrawalla, L Evans, W Wise, D Szyld, A Shiloh, L Eisen, P Mayo. “Critical Care Ultrasound Skill and Knowledge Retention in Fellows After an Introductory Course.” American Journal of Respiratory and Critical Care Medicine. 2013; 187:A5305
  13. P Bhatraju, P Patrawalla, H Horowitz, L Trieu, S Ahuja, E Leibert. “A Retrospective Review Identifying Errors In Isolation Of Patients With Infectious Tuberculosis.” A48. Tuberculosis in Vulnerable and Special Populations. May 1, 2013, A1659-A1659
  14. Agarwala, P; Kim, HJ; Patrawalla, P; Nolan, A. “Massive Hemoptysis In A Patient With World Trade Center Chronic Airways Inflammation.” American journal of respiratory & critical care medicine — id: 1082572, year: 2014, vol: 189, page: A6509

 

 

Back to top

Samuel O. Acquah

Samuel O. Acquah

Director of Medical Intensive Care Unit, Assistant Professor, Icahn School of Medicine at Mount Sinai

Samuel Acquah, MD, FCCP is an Assistant Professor of Medicine at the Albert Einstein School of Medicine and currently serves as the Director of the Medical Intensive Care Unit, the Director of Endobronchial Ultrasound and is the Physician Leader of the Rapid Response Team.

Dr. Samuel Acquah completed his residency in Internal Medicine at Mount Sinai Beth Israel, NY in 1994 where stayed on to and went on to do a fellowship in Pulmonary and Critical Care Medicine at Beth Israel, NY which he completed in 1997. He is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine and has been with the Division since January of 1998 after working for the Health and Hospitals Corporation at Metropolitan Hospital.

Dr. Acquah is interested in a wide range of pulmonary diseases and has a busy outpatient practice caring for patients with asthma, COPD, chronic cough and Interstitial Lung diseases. He has a special interest in sarcoidosis, collagen-vascular lung diseases, pleural diseases, and lung cancer. Dr. Acquah is part of the Multidisciplinary Lung Cancer Program in collaboration with Thoracic surgery, Oncology and Radiation Oncology.

Dr. Acquah is renowned as an Advanced Bronchoscopist specializing in the use of Endobronchial Ultrasound (EBUS). He was one of the first pulmonologist to do EBUS and he has personally done over a 1000 of these procedures. In addition, he has trained several physicians who have started their own EBUS programs. He regularly uses EBUS for the non-invasive staging of the mediastinum and for the diagnosis of sarcoidosis and lymphoma. The use of EBUS in these patients has allowed them to be spared the traditionally used surgical procedure of mediastinoscopy.

Dr Acquah is also expert in the use of critical care ultrasonography, recently serving as Co-Director of the National Courses in Advanced Pleural, Vascular, and Echocardiographic Ultrasound for the American College of Chest Physicians. In his practice he has long used his expert skills in pleural ultrasonography to manage pleural diseases using pleural biopsy, pleurodesis and the insertion of indwelling pleural catheters (PleuRx).

As the director of the Medical Intensive Care Unit at Beth Israel, he has a special interest in developing ICU protocols to improve patient care by ICU and to eliminate hospital acquired infections.

Dr. Acquah also serves as the leader of the Rapid Response Team that is used to bring critical care to the bedside of patients who manifest a rapid decline in their medical condition. He is expert at advanced airway management and critical care ultrasonography. Dr. Acquah has done over 200 percutaneous tracheostomies and has trained many physicians in the technique.

Dr. Samuel Acquah research interests include using EBUS in staging lung cancer and for the diagnosis of enlarged lymph nodes in a variety of diseases.

Dr. Acquah has several publications in peer reviewed journals and is a member of the American College of Chest Physicians, the American Thoracic Society, and the Society for Critical Care Medicine.

Original Articles

  1. Wong M MD, Dayrit F MD, Acquah S MD, Mayo P MD; Comparison of High Dose Inhaled Flunisolide to Systemic Corticosteroids in Severe Adult Asthma Chest 122(4):1208-1213 Oct 2002
  2. A Hedge MD, Lewis Eisen, MD, Samuel Acquah, MD, Paul Mayo, MD outcome of BVM ventilation performed by Medical housestaff trained using a computerized patient simulator with scenario based training during emergency endotracheal intubation Chest 2007

Abstracts

  1. Cruz E, Rizk D, Acquah S . Preliminary data on failure to recognize early warning signs prior to rapid response events or codes American Thoracic Society Conference May 2012
  2. Hwang C, Acquah S. Barriers to effective RRT implementation American College of Chest Physicians Meeting October 2000
  3. Palmero V, Klatchko T, Aslam H, Kory P, Acquah S. Diagnostic Accuracy of Cytopathologic Patterns Found on EBUS FNA in Patients with Suspected Pulmonary Sarcoidosis, American College of Chest Physicians Meeting Oct 2011
  4. Acquah S,Pellecchia C, Kory P, Hwang C. Team Performance Assessment during Rapid Response Event American College of Chest Medicine Conference Oct 2011
  5. Sharif M, Ahuja J, Annan E, Aslam H, Acquah S. Nurse directed Sedation and Glucose management protocol in the ICU: A quality improvement project American Thoracic Society Meeting May 2012
  6. Acquah S, Villamena PC, Soliman A, Rosen MJ: Are chest radiographs necessary after thoracentesis? Chest 1995;108:190S

Meeting Presentations

  1. Inflammatory pseudotumor associated with Mycobacterium-avium complex infection Vanessa Ribauldo MD, S Acquah MD.
  2. A patient presenting with lung cavities, endobronchial nodules, diffuse alveolar hemorrhage, microthrombi and a positive C-ANCA. Louis Eisen MD, S Acquah MD.
  3. Lemieeres Syndrome resulting in Septic Shock and the ARDS Joseph Matthew MD, Samuel Acquah MD, American College of Chest Physicians 2006
  4. Worsening Dypsnea on exertion and an occasional cough in a 25 year old woman. Glen C, Acquah S. American Thoracic Society Conference 2012

Invited Speaker at Regional Meetings

  1. Practical issues in Thoracic oncology for the Clinician - Princeton Club, NY ,May 2010
  2. "Bronchoscopy in the ICU with a focus on VAP" – Bronchoscopy for the Pulmonary Fellow Conference, Mount Sinai Beth Israel 2010
Back to top

Roxana Sulica, MD

Dr. Roxana Sulica

Director, Pulmonary Hypertension Program, Assistant Professor, Icahn School of Medicine at Mount Sinai

Dr. Sulica received her medical degree from the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. She received her internal medicine training at the Albert Einstein College of Medicine, Bronx, New York. Dr. Sulica completed her Fellowship in Pulmonary Critical Care and a dedicated Clinical and Research Fellowship in Pulmonary Hypertension at Mount Sinai School of Medicine in New York, New York.

She has authored numerous papers in the area of pulmonary hypertension and presented at a variety of international and national meetings, seminars, conferences, symposia, and grand rounds activities. Dr. Sulica has served on the editorial board of the journal Advances in Pulmonary Hypertension, as well as a reviewer for numerous scientific journals, including Chest, Critical Care Medicine, Respiratory Medicine and Mount Sinai Journal of Medicine. She currently serves as Principal Investigator in several international, multicenter trials examining novel treatments for pulmonary hypertension

Publications

  1. Sulica R, Teirstein AS, and Padilla ML: "Lung transplantation in Interstitial Lung Disease", Current Opinion in Pulmonary Medicine, September 2001; 7(5): 314-22.
  2. Sulica R, Dinh H, Fuster V, and Poon M: "Beneficial Effect of Acute Sildenafil Administration in Pulmonary Hypertension secondary to Pulmonary Fibrosis" (editorial), Hurst’s The Heart on line, October 2002.
  3. Sulica R and Poon M: "Current Medical Treatment of Pulmonary Arterial Hypertension", The Mount Sinai Journal of Medicine, March 2004; 71(2): 103-114
  4. Sulica R, Emre S, and Poon M: "Living-related Liver Transplantation and Porto-pulmonary Hypertension", Congestive Heart Failure 2004; 10(4): 192-4.
  5. Sulica R and DePalo L. Treatment Options in Portopulmonary Hypertension. Advances in Pulmonary Hypertension 2004, 3(4): 18-22.
  6. Sulica R, Dinh HV, Dunsky K, Fuster V and Poon M: "The Acute Hemodynamic Effect of Intravenous Nitroglycerin and Dipyridamole in Patients with Pulmonary Arterial Hypertension. Comparison with Intravenous Epoprostenol." Congestive Heart Failure 2005 (May-June); 11(3): 139-44.
  7. Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, and Padilla ML. "Distinctive Clinical, Radiographic and Pulmonary Functional Characteristics of Patients with Sarcoidosis-related Pulmonary Hypertension." Chest 2005 Sep; 128 (3): 1483-9.
  8. Sulica R and Poon M. "Medical Therapeutics for Pulmonary Arterial Hypertension: from Basic Science and Clinical Trial Design to Evidence-based Medicine". Expert Review of Cardiovascular Therapy 2005 Mar; 3(2): 347-60.
  9. Sulica R and DePalo L. "Role of Inhaled Iloprost as Emerging Therapeutic Option in Pulmonary Arterial Hypertension." Long Term Healthcare 2005 (April).
  10. Widera E and Sulica R. "Pulmonary Artery Sarcoma Misdiagnosed as Chronic Thromboembolic Pulmonary Hypertension". Mount Sinai Journal of Medicine 2005; 72(6) 360-4.
  11. Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O’Donnell TP, Mehta, D, Fuster V, Rajagopalan S. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol. 2007 Aug 15;100(4):731-5. Epub 2007 Jun 27.
  12. Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, Macaluso F, Fuster V Rajagopalan S. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology. 2007 Apr;243(1):63-9.
  13. Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein A, Dellegrottaglie S, Fuster V, Rajagopalan S, Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology. 2007 Apr;243(1):70-9. Epub 2007 Feb 28.
  14. Palmero V and Sulica R, Pulmonary hypertension in Sarcoidosis. Semin Respir Crit Care Med 2010: 31:494-500

Book Editor

  1. Pulmonary Hypertension - From Bench Research to Clinical Challenges" Publisher InTech, December 2011, ISBN 978-953-307-835-9
  2. Palmero V, Factor P, Sulica R "Sarcoidosis Associated Pulmonary Hypertension", in "Pulmonary Hypertension - From Bench Research to Clinical Challenges" Publisher InTech, December 2011, ISBN 978-953-307-835-9

Recent Abstracts

  1. Palmero V, Sulica R: Bosentan For The Treatment Of Sarcoidosis-Associated Pulmonary Hypertension American Thoracic Society Meeting Denver 2011
  2. Tulliano G, Sulica R: Distinctive hemodynamic Profile Of Patients With HIV-Related Pulmonary Arterial Hypertension With Concomitant Portal Hypertension American Thoracic Society Meeting Denver 2011
  3. Channick RN, Frantz RP, Kawut SM, Palevsky H, Tumuliri R, Sulica R, Benton W, deBoisblanc B: A Multicenter, Retrospective Study of patients With Pulmonary Arterial Hypertension Transitioned From Parenteral Prostacyclin Therapy To Inhaled Iloprost. American Thoracic Society Meeting Denver 2011
  4. Sulica R, Natanzon A Incidence of Pleural Effusions in Patients with Pulmonary Arterial Hypertension and Chronically Elevated Right Atrial Pressure American Thoracic Society Meeting New Orleans 2010
  5. Sulica R, Thiagarajah P, Hanon S, Schweitzer P. Low Prevalence of Arrhythmias in Patients with Pulmonary Arterial Hypertension American Thoracic Society Meeting San Diego 2009

invited Presentations (International, National, Local Meetings)

  1. "End-points in clinical trials of sarcoidosis-associated pulmonary hypertension" WASOG meeting Maastricht Holland June 2011
  2. "Management of Sarcoidosis-Associated Pulmonary Hypertension" Session: Management of Sarcoidosis American Thoracic Society International Conference Denver Alvin Teirstein Memorial Symposium May 2011
  3. Pulmonary Hypertension Association – Sponsored Preceptorship: A Collaborative Approach for Clinicians on the Front Line. Course co-Director and member of the planning group, July 2010- November 2011; "Treatment of PAH" and "PAH in Connective Tissue Disease"
  4. "Treatment of PAH" Beth Israel Heart Institute Course "Update on Cardiology" October 2009
  5. "Endothelin Receptor Antagonism in COPD-related Pulmonary Hypertension" Kenneth Moser Symposium American Thoracic Society International Conference San Francisco May 2007
  6. "Advances in Pulmonary Hypertension" NYSAC &PR Metro Region Annual Conference 2007 Cardiac And Pulmonary Rehabilitation: Our Common Ground, June 2007
  7. "Bring on the Debate: ERAs vs. PDE 5 inhibitors as First Line Therapy" 2007 PH resource Network Symposium Washington DC, October 2007
  8. "PAH therapies" PAH Symposium Current Approaches and Future Expectations CME conference organized by the Pulmonary Hypertension Association New York September 8, 2007
Back to top

Patricia Walker, MD

Patricia Walker, MD

Co-Director Cystic Fibrosis Center

Patricia Walker, M.D. specializes in the care and treatment of adults with cystic fibrosis (CF). She serves as Co-Director of Beth Israel’s Cystic Fibrosis Center, and was recently appointed Acting Division Chief of Pulmonary, Critical Care and Sleep Medicine.

Dr. Walker conducts and oversees a wide variety of CF clinical research, including cutting edge trials on gene modulation investigational therapies, inhaled antibiotics, and the treatment of digestive complications of CF destined to influence pulmonary outcomes. Under her direction, the CF Center was successful in obtaining distinction as a Therapeutic Development Center for CF research trials. The CF team was able to establish a nasal potential difference lab, one of only a few such centers to do so in the Northeast. The team at the CF Center has been active in developing a multidisciplinary and integrative approach to the care of CF patients. She has lectured at numerous local and international scientific meetings.

Dr. Walker came to Mount Sinai Beth Israel from St. Vincent’s Hospital Manhattan in 2010 where she was the also the presiding Chief of Pulmonary Medicine and Co-Director of the Cystic Fibrosis Center.

Dr. Walker’s medical training includes a residency in Internal Medicine at Saint Vincent’s Hospital in Manhattan, and Fellowship Training in Pulmonary and Critical Care Medicine at Memorial Sloan-Kettering Cancer Center. She is board certified in Internal Medicine, Pulmonary Disease and Palliative Care Medicine.

Back to top

Maria N. Berdella, MD

Dr. Maria Berdella

Co-Director of the Cystic Fibrosis Center

Dr. Berdella serves as the Co-Director of the Cystic Fibrosis Center in the Department of Pediatrics and Pulmonary Medicine at Mount Sinai Beth Israel and specializes in the care of patients with cystic fibrosis. The center relocated from Saint Vincent’s Hospital and Medical Center in June 2010 and received full Accreditation from the Cystic Fibrosis Foundation as well as a designation of a specialized center for Cystic Fibrosis Newborn Screening from the Department of Health. It is also a Designated Cystic Fibrosis Research Center.

Dr. Berdella did her Pediatric and post-graduate training at Saint Vincents Medical Center and has been Co-Director of the Center since 1998. She specialized in the care of patients with Cystic Fibrosis.

Dr. Berdella has been involved in many Cystic Fibrosis research trials to help move the science forward. She is currently the Principal Investigator at Beth Israel for Vertex 770, a new drug that targets the genetic defect in patients with Cystic Fibrosis, which has given great hope to this population of patients.

Dr. Berdella lectures on Cystic Fibrosis at many local and international meetings, is a member of the Newborn Screening Consortium for NY State and sits on the Board of the Cystic Fibrosis New York Chapter.

Back to top

Albert Miller, MD

Dr. Albert Miller

Director of the Pulmonary Function Laboratory Clinical Professor of Medicine, Albert Einstein College of Medicine Emeritus Professor of Clinical Medicine, New York Medical College Adjunct Clinical Professor of Occupational Medicine, Emeritus Clinical Professor of Medicine, Mount Sinai School of Medicine Expert Reader for Pneumoconioses, National Institute of Occupational Safety and Health and American College of Radiology

Dr. Albert Miller joined Beth Israel in 2009 as the Director of the Pulmonary Function Laboratory. Long one of the most recognized names in Pulmonary and Occupational Medicine, he is an internationally recognized expert in many areas of Pulmonary Medicine, including Cardiorespiratory Physiology, Clinical Pulmonary Function, Incremental Exercise tests, Environmental and Occupational Lung Diseases, Asbestosis and Asbestos-related Diseases, Sarcoidosis, World Trade Center Respiratory Disorders, Respiratory Epidemiology, Reference standards, Forensic Pulmonology, Disability Evaluation, and the Interactions between Science and Law.

His contribution to the literature and body of knowledge in many of the above areas are vast, having authored and co-authored 10 textbooks, over 100 peer-reviewed articles, multiple textbook chapters, invited topic reviews, and abstracts and presentations too numerous to list here. Below is a selection of his most referenced papers and textbooks.

Selection of Textbooks and Papers

Most Popular Textbooks

  1. Miller A, (editor) Pulmonary Function Tests in Clinical and Occupational Lung Disease. Grune & Stratton, Orlando, 482 pp, 1986.
  2. Miller A, (editor) Pulmonary Function Tests: A Guide for the Student and House Officer. Grune & Stratton, Orlando, 275 pp, 1987.

Most Referenced Peer-Reviewed Articles

  1. Manowitz A, Sedlar M, Griffin M, Miller A, Miller J, Markowitz S. Use of BMI guidelines and individual dose tracking to minimize radiation exposure from low-dose helical chest CT scanning in a lung cancer screening program. Acad. Radiol 19:84-88, 2012
  2. Rom WN, Miller A: Unexpected longevity inpatients with severe kyphoscoliosis. Thorax 33: 106-110, 1978.
  3. Miller A, Chuang MT, Warshaw R, Smith H Jr., Selikoff IJ: Clinical validation of automated spirometry used in surveys of large occupational groups: Comparison with conventional water spirometry. Arch Environ Health 34: 266-273, 1979.
  4. Miller A, Elliot JC, Thornton JC, Warshaw R, Geiger M, Anderson H, Selikoff IJ: Comparison of Spirometry performed on the same subjects by two teams using similar instruments: An investigation of variability in prevalence of impairment. Environ Research 21: 229-234, 1980.
  5. Miller A, Thornton JC: The interpretation of Spirometric measurements in epidemiological surveys. Environ Research 23: 444-468, 1980.
  6. Miller A: The vanishing lung syndrome associated with pulmonary Sarcoidosis. Brit J Dis Chest 75: 209-214, 1981.
  7. Miller A, Einstein K, Thornton J, Teirstein AS, Siltzbach LE: Physiologic classification and staging of Sarcoidosis, in Eighth International Conference on Sarcoidosis and other Granulomatous Disease. Williams WJ and Davies BH, editors, Alpha Omega Publishing Ltd., Cardiff, pp 331-336, 1980.
  8. Miller A, Teirstein AS, Selikoff IJ: Ventilatory failure due to asbestos pleurisy. Am J Med 75: 911-919, 1983.
  9. Montner P, Miller A, Calhoun F: Tracheal diameter as a predictor of pulmonary function. Lung 162: 115-121, 1984.
  10. Miller A, Thornton JC, Warshaw R, Bernstein J, Teirstein AS, Selikoff IJ: Mean an instantaneous expiratory flows, FVC and FEV1: Prediction equations for non-smokers and smokers from a random sample of Michigan, a large industrial state. Bull Physiopath Resp. 22: 589-597, 1986
  11. Miller A, Thornton JC, Anderson HA, Selikoff IJ: Prevalence of clinical respiratory abnormalities by sex and smoking history in a representative sample of the adult population of Michigan. Chest 94: 1187-1194, 1988.
  12. Miller A: Chronic pleuritic pain in four patients with asbestos induced pleural fibrosis. Br I Industr Med 47:147-153, 1990.
  13. Miller A: A simple Spiro metric clue to asthma: Airways obstruction suggested by negative or reduced forced expiratory reserve volume despite normal FEVI/FVC ratio. Mt Sinai J Med 57:85-92, 1990.
  14. Miller A, Warshaw R, Thornton JC: Prevalence of spirometric abnormalities in a representative sample of the population of Michigan. Am J Industr Med 19:473 - 486, 1991.
  15. Miller A, Lilis R, Godblod J, Chan E, Selikoff U: Relationship of pulmonary function to radiographic interstitial fibrosis in 2611 long-term asbestos insulators: An assessment of the ILO profusion score. Amer Rev Respir Dis 145:263-270, 1992.
  16. Lilis R, Miller A, Godblod J, Chan E, Benkert S, Wu X, Selikoff IJ: Comparative quantative evaluation of pleural fibrosis and its effects on pulmonary function in two large asbestos exposed occupational groups-insulators and sheet metalworkers. Environ Res 59:49-66, 1992.
  17. Kilburn KH, Warshaw RH, Thornton JC, Thornton K, Miller A: Predictive equations for total lung capacity and residual volume calculated from radiographs in a random sample of the Michigan population, Thorax 49:519-523, 1992.
  18. Miller A, Miller JA: Diffuse pleural thickening superimposed on circumscribed pleural thickening related to asbestos. Am J Industr Med 23:859-872, 1993.
  19. Miller A, Bhuptani A, Sloane MF, Brown LK, Teirstein AS: Cardiorespiratory responses to incremental exercise in patients with asbestos - related pleural thickening and normal or slightly abnormal lung function. CHEST 103:1045-1050, 1993.
  20. Miller A, Lilis R, Godblod J, Chan E, Wu X, Selikoff IJ: Spirometric impairments in long term insulators: Relationships to duration of exposure, smoking and radiographic abnormalities.CHEST 105:175-182, 1994.
  21. Brown LK, Miller A Pilipski M, Lau T: Forced mid expiratory time: Reference values and the effect of cigarette smoking. Lung 173: 35-46, 1995.
  22. Zimmerman MI, Miller A, Brown LK, Bhuptani A, Sloane MF, Teirstein AS. Estimated versus actual versus values for dead space tidal volume ratios during incremental exercise in patients for dyspnea. CHEST 106:131-136, 1995.
  23. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS: Cardio respiratory response to incremental exercise in sarcoidosis patients with normal spirometry. CHEST 107: 323-329,1995,
  24. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS: Cardio respiratory response to incremental exercise in sarcoidosis patients with normal spirometry. CHEST 107: 323-329,1995,
  25. Rosen MJ, Lou Y, Kvale PA, Rao AV, Jordan MC, Miller A, Glassroth J, Reichrnan LB,Wallace JM, Hopewell PC: Pulmonary Function tests in HIV infected persons without AIDS. Am J Resp Crit Care Med 152:738-745, 1995
  26. Miller A, Lilis R, Godbold J, Wu X. Relationship of Spirometric Function to radiographic interstitial fibrosis I two large work forces exposed to asbestos: An evaluation of the ILO profusion score. Occ Environ Med 53: 808-812, 1996.
  27. Brown LK, Miller A, Bhuptani A, Sloane MF, Zimmerman MI, Schilero G, Eng CM, Desnick RJ. Pulmonary involvement in Fabry disease. AM J Resp Crit Care Med 155: 1004-1010, 1997.
  28. Sadeh JS, Miller A, Kukin ML. Non-invasive measurement of cardiac output by an acetylene uptake technique and simultaneous comparison with thermodilution in ICU patients. CHEST 111: 295-1300, 1997.
  29. Miller A, Brown LK, Pastores GM, Desnick RJ. Pulmonary involvement in Type 1 Gaucher Disease: Functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genetics 63:368-376, 2003.
  30. Miller A, Markowitz S, Manowitz A, Miller JA. Lung cancer screening using low-dose high- resolution CT Scanning in a high-risk workforce: 3500 nuclear fuel workers in three US States. CHEST 125:152S-153S, 2004.
  31. Guidotti TL, Miller A, Christiani D, Wagner G, Balmes J, Harber P, Brodkin CA, Rom W, Hillerdal G, Harbut M, Green FHY. Diagnosis and initial management of non-malignant diseases due to asbestos. Official Statement of the American Thoracic Society. Am J Resp Crit Care Med 170:691-715, 2004.
  32. Guidotti TL, Miller A, Christiani D, Wagner G, Balmes J, Harber P, Brodkin CA, Rom W, Hillerdal G, Harbut M, Green FHY. Diagnosis and initial management of non-malignant diseases due to asbestos. Official Statement of the American Thoracic Society. Am J Resp Crit Care Med 170:691-715, 2004.
  33. Miller A. Mesothelioma in household contacts of Asbestos-Exposed Workers: 32 U.S. Cases since 1990. AmJ Ind Med 47:458-462, 2005.
  34. Mann JM, Sha KK, Kline G, Breuer F, Miller A. World Trade Center Dyspnea: Bronchiolitis obliterans with functional improvement: A Case Report. AmJ Ind Med 48 225, 2005.
  35. Guidotti, TL, Miller A, Christiani D, Wagner G, Balmes J, Harber P, Brodkin CA, Rom W, Hillerdal G, Harbut M, Green FHY. Nonmalignant asbestos-related disease: Diagnosis and early management. Clin Pulm Med, 14:82-92, 2007.
  36. Miller A, Palecki A. Restrictive impairment in patients with asthma. Resp Med, 101:272-276, 2007.
  37. Markowitz, SB, Miller A, Miller J, Manowitz A, Kieding S, Sider L, Morabia A. Ability of low-dose helical computed tomography to distinguish between benign and malignant non-calcified lung nodules. Chest, 131:1028-1034, 2007.

Original Peer Reviewed Reports as one of the International Early Lung Cancer Action Program Investigators.

  1. CT Screening for Lung Cancer: The relationship of disease stage to tumor size. Arch Intern Med 2006, 166:321-325.
  2. Women’s Susceptibility to Tobacco Carcinogens and their survival upon diagnosis of lung cancer. JAMA 2006.
  3. Survival of patients with Stage I Lung Cancer detected on CT Screening. NEJM, 2006. 355:1763-71
  4. Lung cancers diagnosed by annual CT screening: Volume doubling times. Radiology, in press

Editorials, Commentaries

  1. Guidotti TL, Prezant D, Dela Hoz RE, Miller A. The evolving Spectrum of Pulmonary Disease in Respondents to the World Trade Center Tragedy, Am J Indust Med. 54:649-660,2011.
  2. Miller A, Enright P. PFT interpretive Strategies: American Thoracic Society/European Respiratory Society 2005 Guideline Gaps, Resp Care, in press

Alfredo Astua, MD

Alfredo Astua, MD

Director of Sleep Medicine, Assistant Professor of Clinical Medicine, Icahn School of Medicine at Mount Sinai

Dr. Alfredo Astua is the Director of Sleep Medicine at Beth Israel Mount Sinai. For over 6 years, Dr. Astua has been assisting his patients with sleep problems, such as sleep apnea, insomnia, narcolepsy, restless legs syndrome and REM behavior disorder by diligently working together with them to address their sleep related issues and complaints. He specializes in interpreting nocturnal polysomnograms, titration studies, split night studies, multiple sleep latency tests, maintenance of wakefulness tests.

Dr Astua also serves as the the Medical Director at the partner United Sleep Diagnostics sleep lab in Manhattan. The lab provides a safe, professional home like environment for all sleep testing provided.

He is responsible for the implementation of all operational procedures and conducts frequent visits to ensure continued highest quality care. He is responsible for training and instructing sleep technicians in all aspects of sleep medicine through didactic as well as formal presentations.

In addition to his significant sleep medicine experience, patients also benefit from Dr. Astua’s deep knowledge of internal medicine and pulmonary diseases which are often associated with sleep disorders.

Dr. Astua’s diverse complimentary medical back ground creates a comprehensive and holistic approach to his view of patient care. He actively integrates his patients to be evaluated by specialties such as cardiology, otolaryngology (ENT), psychiatry, as well as dentistry. The holistic approach drives his patients to seek assistance in fields a diverse as yoga, fitness and relaxation.

In addition to sleep medicine patients, Dr Astua sees general pulmonary patients in his office. These patients undergo regular pulmonary testing that may include pulmonary function testing, chest x-rays, CT imaging of the chest. His patients include those challenged by cough, asthma, COPD, bronchiectasis, as well as overlap syndrome. In addition to the mentioned he sees patients for solitary nodules, lung cancer evaluation as well as smoking cessation. He shares this vast array of knowledge and experience with fellows (specialists in training) as well as medicine residents who regularly rotate through his outpatient office and do rounds with him in the hospital.

Dr. Astua is a graduate of The Mount Sinai – Elmhurst Internal Medicine Residency Program. He has completed his fellowship training in Sleep Medicine (Sleep Disorders Institute), Pulmonary Diseases and Critical Care (Columbia University School of Medicine).

Dr. Astua is Board certified in Sleep Medicine, Pulmonary Diseases, Internal Medicine and Critical Care

To schedule an office visit:
Office Direct: 212-420-2697
Office After Hours: Tel: 212-420-2377
Fax: 1800-888-9132
Email: [email protected]

Back to top

Alexandra Adams, MD

Alexandra Adams, MD

Assistant Professor of Medicine

Dr. Alexandra Adams joined Mount Sinai Beth Israel in 2014 after completing her pulmonary and critical care fellowship at New York University. Prior to this she obtained a B.S. from Cornell University and her medical degree from SUNY Upstate Medical University in Syracuse, NY. She then completed internal medicine training at the University of Rochester Strong Memorial Hospital in Rochester, NY. During her fellowship training at NYU, she was involved in numerous asthma clinical trials and is currently co-investigator for ongoing asthma trials through the Mount Sinai Health System. She also has a broad interest in general pulmonary medicine, including interstitial lung disease, sarcoidosis, bronchiectasis, COPD, and lung cancer. She is skilled in bronchoscopy including endobronchial ultrasound-guided fine needle aspiration, in addition to many other pulmonary and critical care procedures. Dr. Adams is board certified in internal medicine, pulmonary and critical care medicine.

Publications

  1. Bleck B, PhD; Kazeros A, MD; Bakal K, MD; Garcia-Medina L, MD; Adams A, MD; Liu M, PhD; Chiu A, BA; Lee R, MD; Grunig G, PhD; Reibman J, MD. Co-expression of type 2 immune targets in sputum-derived epithelial cells and dendritic cells in asthma. Submitted to Journal of Allergy and Clinical Immunology.
  2. Kazeros A, MD; Bleck B, PhD; Tse D; Lee R, MD; Garcia-Medina L, MD; Adams A, MD; Liu M; Chiu A; Bakal K, MD; Reibman J, MD. In-situ upregulation of thymic stromal lymphopoietin and IL-33 in human sputum epithelial cells in asthma. Submitted to Clinical and Experimental Allergy.
  3. Adams A, MD; Rajmane RC, MD; Zervos M, MD; Suh J, MD; Rajmane O, MD. A Novel Case of EBUS Diagnosis of Bronchogenic Cyst Causing a Correctable Restrictive Ventilatory Defect. A4442 American Thoracic Society 2014
  4. McGann A, MD; Shariat C, MD; Rajmane R, MD. Does Chronic Histoplasmosis Progress to UIP? Meeting Abstract 1388337 Chest 2012
  5. Tsay J, MD; Suh J, MD; Bhatraju P; McGann A, MD; Simsir A, Rajmane R, MD. The Utility of Endobronchial Ultrasound Transbronchial Needle Aspiration as a Tool for Obtaining Lung Cancer Molecular Mutation Profile. A5971 American Thoracic Society 2012 and New York State Thoracic Society 2012
  6. Bui CJ, McGann AC, Middleton FA, Beaman-Hall CM, Vallano ML. Transcriptional profiling of depolarization-dependent phenotypic alterations in primary cultures of developing granule neurons. Brain Res. 2006 Nov 13;1119(1):13-25. Epub 2006 Sep 20. PMID: 16989786
Back to top

Molly (Mary) Harris, MD

Molly (Mary) Harris, MD

Attending Physician, Respiratory and Medical Intensive Care Units, Pulmonary Consultation Service

Dr. Harris joined Mount Sinai Beth Israel in 2014 after completing her fellowship in Pulmonary and Critical Care Medicine at New York Presbyterian Hospital/Weill Cornell Medical College in New York, New York. Prior to her fellowship, Dr. Harris completed her internship and residency in Internal Medicine at the Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx, New York. Originally from Philadelphia, Pennsylvania, Dr. Harris received her BA from the University of Pennsylvania and her MD from Temple University School of Medicine.

Dr. Harris is board certified in Internal Medicine and Pulmonary Disease. Dr. Harris's has extensive research experience and interest in endobronchial ultrasound guided transbronchial needle aspiration of mediastinal lymph nodes for the purpose of studying gene expression as well as in patients with interstitial lung diseases. She is a member of the Society of Critical Care Medicine, American Thoracic Society and the American College of Chest Physicians.

Peer-Reviewed Publications

Chakravarty SD, Harris ME, Schreiner AM, Crow MK. Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review. Seminars in Arthritis and Rheumatism. 2012; 42(2):206-12.

Keene A, Hailpern S, Anees S, Sandhu J, Harris M, Ashton L, Bellin E. Glycemic control in critically ill patients before and after institution of an intensive insulin infusion protocol: Circadian rhythm and the quality duration calculator. Journal of Intensive Care Medicine. 2010; 25:31-38.

Abstracts and Posters
  1. Anees S, Harris M, Keene A. Hypoglycemic incidence before and after an intensive insulin protocol. American Thoracic Society International Conference, May 2009.
  2. Bussell J, Butros L, Harris M. Prospective Study of Intracranial Hemorrhage (ICH) in Children with ITP. Society for Pediatric Research, May 2000.
  3. Bussel, J.B., Harris, M.E., Zelmanovic, D., Chapman, S. The role of platelet parameters in the diagnosis and treatment of immune thrombocytopenic purpura (itp). Blood. 2000; 96:63b.
  4. Harris M, Bussell J. The Role of Platelet Parameters in the Diagnosis and Treatment of Immune Thrombocytopenic Purpura (ITP). American Society of Hematology, December 2000.
  5. Oral Presentations
  6. New York State Thoracic Society, Fellows Forum, Hypersensitivity Pneumonitis, January 2012.

Earle Hayes, DO

Dr. Earle Hayes

Critical Care, Palliative Care/Hospice Program

Dr. Hayes received a BA in marketing from the University of South Florida and an MS in Clinical Psychology from Barry University. He obtained his DO degree from Nova Southeastern University College of Osteopathic Medicine where he received several awards including his class humanitarian awards and the Dean’s award for outstanding accomplishments for providing medical care to underserved populations in Guatemala.

Dr. Hayes completed his internal medicine residency at Yale University in New Haven, CT. During his residency he completed and published data regarding the incidence of psychiatric disorders in next-of-kin of patients who die in the ICU. After his residency, Dr. Hayes completed a critical care medicine fellowship at St. Vincent’s Hospital in Manhattan.

Dr. Hayes has a long-standing interest in palliative care and is a member of the Beth Israel hospital Palliative Care and Hospice Service and has served as a Hospice Medical Director with the Continuum Health Partners Network.

Dr. Hayes is board certified in Internal Medicine, Critical Care Medicine, and Hospice and Palliative Care Medicine. Dr. Hayes currently attends in the Beth Israel Medical ICU and is Director of the nocturnal critical care program. A major contribution to the Division and Fellowship has been his efforts in serving as a Coordinator of the MICU-Palliative Care Initiative, as well as his offering of rotations in Palliative Care to the Pulmonary/Critical Care Fellows.

Education and Training

Internal Medicine Residency

BIBLIOGRAPHY

Peer Reviewed Publications

  1. Mark D. Siegel, MD, FCCP; Earle Hayes, DO, MS; Lauren C. Vanderwerker, PhD; Diane B. Loseth, RN, MSN, APRN, BC-PCM; Holly G. Prigerson, PhD. Psychiatric Illness in the next of kin of patients who die in the intensive care unit. Critical Care Medicine, 2008 , 36 (6), 1722-1728 .
  2. E. Hayes, DO, MS and D.P. Sulmasy, OFM, PhD, MD: E. Hayes Site Primary Investigator: Conflicus International Study, St. Vincent’s Hospital Manhattan one of 12 US sites; December 2006: A One day Prevalence Study on ICU-Conflicts
  3. E. Hayes DO, MS, M. Astiz, MD and D. P. Sulmasy OFM, PhD, MD: Patient, Physician and Surrogate variables associated with a Surrogate’s decision to make a patient DNR, 2006-2007
  4. Mark D. Siegel, MD, FCCP; Earle Hayes, DO, MS; Lauren C. Vanderwerker, PhD; Diane B. Loseth, RN, MSN, APRN, BC-PCM; Holly G. Prigerson, PhD, Psychiatric Illness in the next of kin of patients who die in the intensive care unit, Critical Care Medicine, 2008 , 36 (6), 1722-1728 .

Abstracts

  1. E. Hayes, and M. Siegel. American Thoracic Society National Conference, 2004. Prevalence of and associated risk factors for Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder and Complicated Grief, in family members listed as next of kin of patients who die in the MICU
  2. E. Hayes, M. Astiz, and D. P. Sulmasy. Peter Cyrus-Rizzo III Scientific Seminar, St. Vincent’s Hospital Manhattan. June 2007. Patient, Physician and Surrogate Variables Associated with Decision-Making in the ICU.
  3. E. Hayes, and Bentley, C. Society of Teachers of Family Medicine Conference, 2001. A Cultural and Medical Learning Experience: Medical Missions to Guatemala 2000/2001

Hospital Appointments

  1. Ethics Committee member and Ethics consult service, 2010-present Mount Sinai Beth Israel, Manhattan
  2. Fundamental Critical Care Support Instructor, Jan 2010 completed at SCCM conference

Lectures

  1. Pulmonary Critical Care/Palliative Care Joint Grand Rounds- "Palliative Care Information Act, Family Health Care Decisions Act, Terminal Extubation Protocol"- Oct. 2011
  2. Pulmonary Critical Care/Palliative Care Joint Grand Rounds- "Integrating Palliative Care into the ICU at Mount Sinai Beth Israel"- Palliative Care, MICU, SICU, Oct 2010
  3. Dept. of Medicine Grand Rounds- "Effective Communication at End-of-, Life" Mount Sinai Beth Israel Manhattan, Oct 2011
Back to top

Website designed & developed by w3developing LLC